Regulated information

Vétoquinol announces opening of its first decentralized R&D center in Canada

Monthly information regarding the total number of voting rights and shares making of the share capital

Vétoquinol to market and distribute Vetprofen in the United States

Monthly information regarding the total number of voting rights and shares making of the share capital

3rd quarter revenues confirm promise of
strong growth prospects for 2007

For the nine months ended September 30, 2007, Vétoquinol’s total revenues reached €166.0 M, an increase of 11.3% compared with the
corresponding period in 2006.

Monthly information regarding the total number of voting rights and shares making of the share capital

Reports very good first half, confirming that 2007 performance is set to surpass targets

Presentation of Vétoquinol’s results for the first half of 2007

2007 Half year results

Monthly information regarding the total number of voting rights and shares making of the share capital.

Rapport semestriel 2007 « narratif » (french)

Suite à la publication du 26 juillet dernier, Vétoquinol a réalisé au 1er semestre 2007 un
chiffre d’affaires de 111,1 M€ contre 98,4 M€ au cours de la même période de l’exercice
précédent, soit une progression de 12,9 %.
A cours de change et périmètre constants, la progression est de 10,1 %.